M
059210
vs
YPSN
YPSN
Over the past 12 months, Metabiomed Co Ltd has significantly outperformed YPSN, delivering a return of +27% compared to the YPSN's 24% drop.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
YPSN
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
M
|
Metabiomed Co Ltd
KOSDAQ:059210
|
5 330
KRW
|
|||||
|
Ypsomed Holding AG
SIX:YPSN
|
269
CHF
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
059210, YPSN
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
M
|
Metabiomed Co Ltd
Revenue
|
|||||||||||
|
|
Ypsomed Holding AG
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
059210, YPSN
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
M
|
Metabiomed Co Ltd
KOSDAQ:059210
|
|||||||||
|
|
Ypsomed Holding AG
SIX:YPSN
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
M
|
Metabiomed Co Ltd | ||||
|
|
Ypsomed Holding AG | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
M
|
Metabiomed Co Ltd | ||||
|
|
Ypsomed Holding AG | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
M
|
Metabiomed Co Ltd | ||||
|
|
Ypsomed Holding AG | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
M
|
Metabiomed Co Ltd | ||||
|
|
Ypsomed Holding AG | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
M
|
Metabiomed Co Ltd | ||||
|
|
Ypsomed Holding AG | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
M
|
Metabiomed Co Ltd | ||||
|
|
Ypsomed Holding AG | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
M
|
Metabiomed Co Ltd | ||||
|
|
Ypsomed Holding AG | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
M
|
Metabiomed Co Ltd | ||||
|
|
Ypsomed Holding AG | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
059210, YPSN
Performance Gap
059210, YPSN
Performance By Year
059210, YPSN
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
|
| JP |
|
Hoya Corp
TSE:7741
|
|
| CH |
|
Alcon AG
SIX:ALC
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
